reports
WillScot Announces Investor Conference Schedule for May 2025
WillScot Announces Investor Conference Schedule for May 2025 PHOENIX, April 24, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will participate in the following investor conferences in the upcoming month: Barclays Americas Select Franchise ConferenceDate: May 6, 2025Location: London, United Kingdom Oppenheimer 20th Annual Industrial Growth ConferenceDate: May 7, 2025Location: Virtual Bank of America Industrials, Transportation & Airlines Key Leaders ConferenceD...
WillScot to Announce First Quarter 2025 Results on May 1, 2025
WillScot to Announce First Quarter 2025 Results on May 1, 2025 PHOENIX, April 16, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its first quarter 2025 financial results on May 1, 2025, after market close. The Company’s management team will host a conference call and webcast on May 1, 2025, at 5:30 p.m. EDT to discuss the Company’s results. To access the live call by phone, use the following link by clicking to obtain registration details....
Vishay Precision Group Announces Date for Its First Quarter Fiscal 202...
Vishay Precision Group Announces Date for Its First Quarter Fiscal 2025 Earnings Conference Call MALVERN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will release its financial results for the first quarter fiscal 2025 before the opening of the market on Tuesday, May 6, 2025. Ziv Shoshani, chief executive officer, and Bill Clancy, chief financial officer, will host a conference call that day (Tuesday, May 6, 2025) at 9:00 a.m. U.S. eastern time. To access the conference call, interested pa...
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Di...
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025 – Company generated quarterly sequential growth with Q1 YCANTH® dispensed applicator units rising above 10,000 for the first time in a quarter – – As YCANTH distributor inventory levels have normalized, Company expects that dispensed applicator units will now more closely track demand and gross revenue – WEST CHESTER, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company...
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of ...
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Gavin Corcoran, M.D. to its Board of Directors. “We are pleased to welcome Dr. Gavin Corcoran to our Board of Directors,” said Jayson Rieger, Ph.D., MBA, President and Chief Executive Officer of Verrica Pharmaceuticals. “Gavin is a highly a...
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virt...
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference WEST CHESTER, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. 24th Annual Needham Virtual Healthcare Conference, Apri...
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Med...
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Noah L. Rosenberg, M.D., as Chief Medical Officer. “We are excited to welcome Noah Rosenberg to the Verrica team as our new Chief Medical Officer,” said Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica. “As a highl...
WillScot Announces Expiration of Consent Solicitations and Receipt of ...
WillScot Announces Expiration of Consent Solicitations and Receipt of Consents to Amend its Senior Secured Notes due 2029 and Senior Secured Notes due 2031 PHOENIX, March 24, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, announced the expiration and results of the previously announced Consent Solicitations of its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), soliciting consents (“Consents”) from holders of its existing 6.625% Senior Secured Notes due 2029 (the “2029 Notes”) and ...
WillScot to Nominate Dominick Zarcone as New Independent Director
WillScot to Nominate Dominick Zarcone as New Independent Director Current Chairman Erik Olsson to Retire at 2025 Annual Meeting Following Five-Year Tenure Worthing Jackman to Be Appointed Non-Executive, Independent Chairman of Board PHOENIX, March 24, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that, as part of its ongoing board refreshment efforts, the WillScot Board of Directors (the “Board”) has unanimously approved the nomination of Dominick (Nick) Zarcone to sta...
WillScot Announces Modifications to Consent Solicitations to Amend its...
WillScot Announces Modifications to Consent Solicitations to Amend its Senior Secured Notes Due 2029 and Senior Secured Notes due 2031 PHOENIX, March 17, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced it is amending the Consent Solicitations of its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), soliciting consents (“Consents”) from holders of its existing 6.625% Senior Secured Notes due 2029 (the “2029 Notes”) and the holders of its 7.375% Senior Secured Notes due ...
WillScot Announces Pricing of Senior Secured Notes Offering
WillScot Announces Pricing of Senior Secured Notes Offering PHOENIX, March 12, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced the pricing of the private offering of $500.0 million aggregate principal amount of 6.625% senior secured notes due 2030 (the “Notes”) by its indirect subsidiary Williams Scotsman, Inc. (“WSI”). The Notes were priced at 100% of their face value. The closing of the offering of the Notes is expected to occur on or about March 26, 2025, subject to cus...
WillScot Announces Consent Solicitations to Amend its Senior Secured N...
WillScot Announces Consent Solicitations to Amend its Senior Secured Notes Due 2029 and Senior Secured Notes due 2031 PHOENIX, March 12, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its indirect subsidiary Williams Scotsman, Inc. (“WSI”), will solicit consents (“Consents”) from the holders of its existing 6.625% Senior Secured Notes due 2029 (the “2029 Notes”) and the holders of its 7.375% Senior Secured Notes due 2031 (the “2031 Notes” and, together with the 2029 ...
WillScot Announces $500.0 Million Senior Secured Notes Offering
WillScot Announces $500.0 Million Senior Secured Notes Offering PHOENIX, March 12, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its indirect subsidiary Williams Scotsman, Inc. (“WSI”) plans to offer, subject to market and other conditions, $500.0 million aggregate principal amount of senior secured notes due 2030 (the “Notes”). The Notes will be WSI’s general second lien senior secured obligations, guaranteed on a senior secured basis by each of WSI’s direct and in...
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Fina...
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results – Company generated quarterly sequential growth in YCANTH® dispensed applicator units of 12.3% in Q4’24 concurrent with significantly lower operating expenses – – Company reports positive quarterly revenue earlier than previously disclosed expectations, as new demand resulted in Company’s primary distribution partner ordering applicators of YCANTH during Q4’24 – – Late-stage pipeline continues to advance with programs in basal cell carcinoma (VP-315) and common warts (VP-102/YCANTH) – – Recent...
WillScot Holdings Corp: 1 director
A director at WillScot Holdings Corp bought 10,000 shares at 28.740USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
VPG to Participate in the Sidoti March 2025 Small-Cap Investor Confere...
VPG to Participate in the Sidoti March 2025 Small-Cap Investor Conference MALVERN, Pa., March 10, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, announced that the company will present at the Sidoti March 2025 Small-Cap Virtual Investor Conference on Thursday, March 19, 2025 at 11:30 a.m. ET. A live and on-demand webcast of VPG’s presentation will be available to the public and can be accessed from the following link: , or on VPG’s website: . For more information, or for help arranging a one-on-one meeting at...
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Fi...
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025 WEST CHESTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Tuesday, March 11, 2025, to discuss the Company's financial results for the fourth quarter and full year ending December 31, 2024, and ...
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Hea...
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston WEST CHESTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston. TD Cowen 45th Annual Health Care Conference, Mar...
WillScot Reports Fourth Quarter 2024 Results and Provides 2025 Outlook
WillScot Reports Fourth Quarter 2024 Results and Provides 2025 Outlook PHOENIX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced fourth quarter and full year 2024 results including key performance highlights and market updates. The Company also announced its outlook for full year 2025. Q4 20241,2 Generated revenue of $603 million, gross profit margin percentage of 55.8%, income from continuing operations of $89 million and diluted earnings per share of $0.48.Incr...
WillScot Broadens Capital Allocation by Initiating Cash Dividend Progr...
WillScot Broadens Capital Allocation by Initiating Cash Dividend Program PHOENIX, Feb. 18, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that its Board of Directors (“Board”) has declared the initiation of a quarterly cash dividend program consistent with the Company’s commitment to returning capital to shareholders, while continuing to invest in growth. The first dividend of $0.07 per share will be payable on March 19, 2025, to shareholders of record as of the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.